These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6265707)

  • 21. [Herpes simplex virus type 2: its distribution and relationship to cervical carcinoma].
    Petersen EE; Böcker JR; Fürmaier I; Hillemanns HG
    Dtsch Med Wochenschr; 1972 Dec; 97(50):1936 passim. PubMed ID: 4344976
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
    Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
    Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
    Najem SN; Barton IG; Al-Omar LS; Potter CW
    Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum antibody levels of cytomegalovirus, herpes simplex type I and adenovirus in patients with benign or malignant prostatic neoplasms].
    Peker AF; Erkan I; Ozen HA; Ustaçelebi S; Ozdemir T
    Mikrobiyol Bul; 1986 Jul; 20(3):165-75. PubMed ID: 2436029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
    Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
    Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
    [No Abstract]   [Full Text] [Related]  

  • 28. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. III. Presence of herpes simplex type-2 antibody in sera of subjects who developed cervical neoplasia later in the study.
    Krcmár M; Suchánková A; Kanka J; Vonka V
    Int J Cancer; 1986 Aug; 38(2):161-5. PubMed ID: 3015805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z; Kanka J; Vonka V; Svoboda B
    Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Another view of Herpes Simplex Virus type 2.
    Rotkin ID
    JAMA; 1976 May; 235(20):2188-9. PubMed ID: 178936
    [No Abstract]   [Full Text] [Related]  

  • 32. [Finding of the herpes simplex virus by electron microscopic study of the biopsy from a cervical cancer patient].
    Gushchin BV; Posevaia TA; Gushchina EA; Vanag KA; Grigor'ev VV
    Vopr Virusol; 1983; (3):342-5. PubMed ID: 6310894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary neutralizing activity against herpes simplex virus type 1.
    Gyselink R; Coles D; Ash RJ; Fritz ME
    J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological and serological studies in pregnancy, in women with suspect genital herpes simplex virus or perinatal cytomegalovirus infections, and in women with carcinoma of the cervix.
    Frenkel LD; Crawford MA; Bellanti JA
    IARC Sci Publ (1971); 1978; (24 Pt 2):911-5. PubMed ID: 221413
    [No Abstract]   [Full Text] [Related]  

  • 36. [Seroepidemiological survey of herpes simplex virus type 2 in cervical erosion women].
    Wang YG
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Aug; 9(4):214-6. PubMed ID: 2852541
    [No Abstract]   [Full Text] [Related]  

  • 37. Herpes simplex virus and human papilloma virus in the development of cervical carcinoma.
    Kaufman RH; Adam E
    Clin Obstet Gynecol; 1986 Sep; 29(3):678-92. PubMed ID: 3019599
    [No Abstract]   [Full Text] [Related]  

  • 38. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
    Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
    J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
    Chiphangwi JD
    IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.